Literature DB >> 18419407

Molecular analysis of the Oka vaccine strain of varicella-zoster virus.

Koichi Yamanishi1.   

Abstract

Live attenuated Oka vaccine was subjected to molecular analysis, with the long-term goal of identifying genes in the vaccine strain responsible for its attenuation. Complete genomic sequences for both the Oka parent virus and the Oka vaccine virus were determined and compared. There were differences in only 42 bases between the 2 viruses. More than one-third (15/42) of the nucleotide substitutions in V-Oka were found in open reading frame (ORF) 62. These differences were also observed when sequences of Japanese low-passage clinical isolates of varicella-zoster virus (VZV) were compared with the Oka vaccine strain. The ORF62 gene encodes an immediate early (IE) protein, IE62, that is the major transactivator of VZV and, as such, is critical to initiating the VZV gene expression cascade. Several insertions and deletions were also observed in comparing the 2 sequences, largely in the internal tandem repeat units. Functional differences between the 2 types of Oka virus were also examined. Oka vaccine was found to consist of a mixture of different subpopulations, and the parental Oka virus replicates more efficiently than does the vaccine strain. Development of a bacterial artificial chromosome for VZV expression should lead to the discovery of additional differences in wild and vaccine types and, thus, enhance our understanding of the genetic basis for attenuation of the Oka vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419407     DOI: 10.1086/522122

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Varicella Virus Vaccination in the United States.

Authors:  Jana Shaw; Anne A Gershon
Journal:  Viral Immunol       Date:  2017-11-27       Impact factor: 2.257

2.  Characterization and phylogenetic analysis of Varicella-zoster virus strains isolated from Korean patients.

Authors:  Min Ho Kim; Jeong Seon Jeon; In Kyo Kim; Ji Seon Park; Hosun Park; Ok Sarah Shin; Chan Hee Lee
Journal:  J Microbiol       Date:  2017-07-28       Impact factor: 3.422

3.  Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.

Authors:  Jong Ik Kim; Gyoo Seung Jung; Yu Young Kim; Ga Young Ji; Hyung Seok Kim; Wen Dan Wang; Ho Sun Park; Song Yong Park; Geun Hee Kim; Shi Nae Kwon; Keon Myung Lee; Jin Hyun Ahn; Yeup Yoon; Chan Hee Lee
Journal:  Virol J       Date:  2011-12-16       Impact factor: 4.099

4.  Insights into the pathogenesis of varicella viruses.

Authors:  Océane Sorel; Ilhem Messaoudi
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-06

5.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

6.  Variability of immediate-early gene 62 in german varicella-zoster virus wild-type strains.

Authors:  A Sauerbrei; K Bohn; R Zell; P Wutzler
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 7.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

8.  Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes.

Authors:  Vincent T Chow; Graham A Tipples; Charles Grose
Journal:  Infect Genet Evol       Date:  2012-11-24       Impact factor: 3.342

9.  Analysis of IE62 mutations found in Varicella-Zoster virus vaccine strains for transactivation activity.

Authors:  Hyemin Ko; Gwang Myeong Lee; Ok Sarah Shin; Moon Jung Song; Chan Hee Lee; Young Eui Kim; Jin-Hyun Ahn
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 2.902

10.  Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Authors:  Pieter Meysman; Nicolas De Neuter; Esther Bartholomeus; George Elias; Johan Van den Bergh; Marie-Paule Emonds; Geert W Haasnoot; Steven Heynderickx; Johan Wens; Nele R Michels; Julien Lambert; Eva Lion; Frans H J Claas; Herman Goossens; Evelien Smits; Pierre Van Damme; Viggo Van Tendeloo; Philippe Beutels; Arvid Suls; Geert Mortier; Kris Laukens; Benson Ogunjimi
Journal:  Immunogenetics       Date:  2017-12-01       Impact factor: 3.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.